Opening book details…
Can I read A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer on EtoBox?
A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer by Panagiotis A. Konstantinopoulos; Jung-min Lee; Bo Gao; Rowan Miller; Jung-Yun Lee; Nicoletta Colombo; Ignace Vergote; Kelly M. Credille; Suzanne R. Young; Samuel McNeely; Xuejing Aimee Wang; Aimee Bence Lin; Ronnie Shapira-Frommer is a Medicine article available to read on EtoBox.
What is A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer about?
Objective High-grade serous ovarian cancer, the most frequent type of ovarian cancer, has a poor prognosis and novel treatments are needed for patients with platinum resistant/refractory disease. New therapeutic strategies targeting cell cycle checkpoints, including CHK1 inhibition with prexasertib, may help improve clinical response and overcome resistance. Methods Patients with ovarian cancer (N = 169) were assigned to 4 cohorts as part of the Phase 2 multicenter trial (NCT03414047): Cohort 1: platinum resistant, BRCA-wildtype with ≥3 lines prior therapy; Cohort 2: platinum resistant BRCA-wildtype with <3 lines prior therapy; Cohort 3: platinum resistant, BRCA-mutated with prior PARP inhibitor therapy; Cohort 4: platinum refractory, BRCA-mutated, or BRCA-wildtype with any number of prior therapy lines. The primary endpoint was objective response rate (ORR) and secondary endpoints included disease control rate (DCR), and safety. DNA from tumor biopsies was sequenced to identify biomarkers. Results The ORR in platinum resistant patients (Cohorts 1--3) was 12.1%, and 6.9% in platinum refractory patients. In platinum resistant patients, DCR was 37.1%, and consistent across cohorts. I
Who reads A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Panagiotis A. Konstantinopoulos; Jung-min Lee; Bo Gao; Rowan Miller; Jung-Yun Lee; Nicoletta Colombo; Ignace Vergote; Kelly M. Credille; Suzanne R. Young; Samuel McNeely; Xuejing Aimee Wang; Aimee Bence Lin; Ronnie Shapira-Frommer
- Publisher
- Elsevier BV
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)